Showing 2341-2350 of 2527 results for "".
- CDC Updates Counterfeit Botox Investigationhttps://modernaesthetics.com/news/cdc-updates-counterfeit-botox-investigation/2473576/The Centers for Disease Control and Prevention (CDC), several state and local health departments, and the U.S. Food and Drug Administration (FDA) are investigating reports of harmful reactions among people who received injections of counterfeit or mishandled botulinum toxin, the CDC said in a sta
- YoungMD Connect Review: Tell-All Tribunehttps://modernaesthetics.com/news/youngmd-connect-review-tell-all-tribune/2473573/The Tell-All Tribune aesthetic think tank in Fort Lauderdale, Florida, in April emerged as a groundbreaking collaborative conference, providing a platform where thought leaders in aesthetics converged to shape the future of the field. Under the leadership of course director Shino Bay Aguilera, DO
- Tell-All Tribune Explores Most Important Topics in Aesthetic Medicinehttps://modernaesthetics.com/news/tell-all-tribune-explores-most-important-topics-in-aesthetic-medicine/2473565/The inaugural Tell-All Tribune: An Aesthetic Think Tank was held in Fort Lauderdale, Florida, from April 18-20, and could perhaps be summed up in six words from course director Shino Bay Aguilera, DO: “What we do goes beyond vanity." Along with fellow course directors Michell
- Zubritsky Joins Detergent Brand as Chief Dermatology Advisorhttps://modernaesthetics.com/news/zubritsky-joins-detergent-brand-as-chief-dermatology-advisor/2473562/Board-certified dermatologist and popular social media influencer Lindsey Zubritsky, MD, FAAD, has joined all® free clear as
- Murad Alam, MD, FAAD, Elected American Academy of Dermatology President for 2026https://modernaesthetics.com/news/murad-alam-md-faad-elected-american-academy-of-dermatology-president-for-2026/2473558/Chicago-based board-certified dermatologist Murad Alam, MD, FAAD, has been elected to lead the American Academy of Dermatology (AAD). He will be installed as president-elect in March 2025 and hold the office of president for 1 year beginning in March 2026. AAD is the world’s large
- Botulism-Like Symptoms Linked to Suspected Fake Cosmetic Injections in Illinoishttps://modernaesthetics.com/news/botulism-like-symptoms-linked-to-suspected-fake-cosmetic-injections-in-illinois/2473557/The Illinois Department of Public Health (IDPH) has issued a warning to healthcare facilities, particularly hospital ERs, urging heightened vigilance for patients exhibiting symptoms resembling botulism. The advisory follows the identification of a clus
- Exosome X Mitochondrial Technology: Elevai Labs Enters Into Licensing Agreement With Yuva Bioscienceshttps://modernaesthetics.com/news/exosome-x-mitochondrial-technologies-elevai-labs-enters-into-licensing-agreement-with-yuva-biosciences/2473536/Elevai Labs, Inc. signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx (Precision Regenerative Exosome Technology) in topical skincare. The potential collab could com
- The Art of Saying Nohttps://modernaesthetics.com/news/the-art-of-saying-no/2473533/Most cosmetic dermatologists and plastic surgeons have encountered a patient (or patients) with unreasonable expectations and know intuitively that these patients won’t be satisfied with the outcome of a requested procedure. Still, it can be hard to say no, especially when the doc
- Allergan Aesthetics, University Lab Partners Announce the Golden Passport Pitch Competition to Accelerate Aesthetics Start-Upshttps://modernaesthetics.com/news/allergan-aesthetics-university-lab-partners-announce-the-golden-passport-pitch-competition-to-accelerate-aesthetics-start-ups/2473509/University Lab Partners (ULP) is announcing the Golden Passport pitch competition for aesthetic startups sponsored by Allergan Aesthetics, an AbbVie Company. The Golden Passport provides the winner with a lab bench for one year and opportunities to engage with industry mentors including
- RelabotulinumtoxinA Update from Galdermahttps://modernaesthetics.com/news/relabotulinumtoxina-update-from-galderma/2473504/The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Galderma related to its pending Biologics License Application (BLA) for RelabotulinumtoxinA for the treatment of moderate-to-severe glabellar lines associated with corrugator and/or procerus muscle activity